Mary-Ellen Martin

发表

Risk of invasive fungal infections in patients with high‐risk MDS and AML receiving hypomethylating agents

Shannon R. McCurdy, D. Porter, A. Perl, 2020, American journal of hematology.

Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant

R. Emmons, T. Klumpp, Manish Sharma, 2012, American journal of hematology.

Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

Shannon R. McCurdy, M. Carroll, D. Porter, 2022, Blood advances.

Animal Model Immunopathology and Ehrlichial Propagation Are Regulated by Interferon- g and Interleukin-10 in a Murine Model of Human Granulocytic Ehrlichiosis

J. Dumler, Mary-Ellen Martin, K. Caspersen, 2001 .

Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia

Shannon R. McCurdy, D. Porter, K. Pratz, 2022, Leukemia & lymphoma.

Allogeneic hematopoietic stem cell transplantation for primary cutaneous T cell lymphomas

D. Porter, Ellen J. Kim, A. Rook, 2011, Bone Marrow Transplantation.

Cardiac Tissue-Specific Transcription Factor ThatRecognizes theMEF-2Siteinthe MyosinLight Chain-2 Promoter

Ming Zhou, Mary-Ellen Martin, 1993 .

Low dose total body irradiation added to fludarabine and busulfan reduced intensity conditioning reduces graft failure in patients with myelofibrosis.

D. Porter, A. Maity, J. Plastaras, 2022, Transplantation and cellular therapy.

Characterization of Pericarditis Following Allogeneic Hematopoietic Cell Transplant.

Shannon R. McCurdy, B. Ky, J. Carver, 2021, Transplantation and cellular therapy.

Clofarabine and busulfan myeloablative conditioning in allogeneic hematopoietic cell transplant for patients with active myeloid malignancies.

Shannon R. McCurdy, D. Porter, K. Pratz, 2022, Transplantation and cellular therapy.

Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.

D. Porter, D. Babushok, S. Luger, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay.

Shannon R. McCurdy, D. Porter, D. Babushok, 2021, Transplantation and cellular therapy.

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment and Length of Hospitalization in Myeloablative Allogeneic Hematopoietic Transplantation

Shannon R. McCurdy, D. Porter, D. Babushok, 2019, Biology of Blood and Marrow Transplantation.

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization

Shannon R. McCurdy, D. Porter, D. Babushok, 2018, Blood.

MLL targets SET domain methyltransferase activity to Hox gene promoters.

Thomas A Milne, C. Allis, J. Hess, 2002, Molecular cell.

Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation

Shannon R. McCurdy, D. Porter, K. Pratz, 2020, Leukemia & lymphoma.

Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization

Arndt Borkhardt, Sumit K. Chanda, S. Chanda, 2004, Molecular and Cellular Biology.

Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide

Shannon R. McCurdy, D. Porter, K. Pratz, 2022, Leukemia & lymphoma.

MLL associates specifically with a subset of transcriptionally active target genes.

J. Hess, Y. Dou, R. Roeder, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Dimerization of MLL fusion proteins immortalizes hematopoietic cells.

J. Hess, W. Shen, T. Milne, 2003, Cancer cell.

Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.

J. Hess, T. Milne, H. Brock, 2005, Cancer research.

Multiple Histone Modifications Locus , Promoting Transcription and Hox a 9 Region of the Leukemogenic MLL Fusion Proteins Bind across a Broad

J. Hess, T. Milne, H. Brock, 2005 .

Tacrolimus induced pseudogout following allogeneic hematopoietic cell transplant

Shannon R. McCurdy, S. Luger, Colin Ligon, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Lack of effect of donor‐recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation

J. Ulicny, R. Emmons, B. Wirk, 2007, Transfusion.

Real World Survival Outcomes of CPX-351 Versus Venetoclax and Azacitadine for Initial Therapy in Adult Acute Myeloid Leukemia

Shannon R. McCurdy, D. Porter, K. Pratz, 2021, Blood.

Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract

D. Porter, D. Babushok, S. Luger, 2019, Bone Marrow Transplantation.

Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant

Shannon R. McCurdy, D. Porter, K. Pratz, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Limited FISH Testing for MDS-Defining Cytogenetic Abnormalities Rapidly Identifies Patients with Newly Diagnosed AML Eligible for CPX-351

Shannon R. McCurdy, A. Bagg, C. McMahon, 2018, Blood.

Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia

Shannon R. McCurdy, M. Carroll, D. Porter, 2023, American journal of hematology.

Venous Thromboembolism Following Pegaspargase in Adults Receiving Antithrombin Supplementation: A Single Center Characterization of Risk Factors and an Assessment of Supplementation Practice

Shannon R. McCurdy, D. Porter, A. Perl, 2018, Blood.

CART22-65s Co-Administered with huCART19 in Adult Patients with Relapsed or Refractory ALL

Shannon R. McCurdy, D. Porter, B. Levine, 2021, Blood.

Risk of Invasive Fungal Infections in Patients with High-Risk MDS and AML Receiving Hypomethylating Agents

Shannon R. McCurdy, D. Porter, A. Perl, 2018, Blood.